Open Access

Detection of MMTV-Like sequences in Moroccan breast cancer cases

  • Meriem Slaoui1, 2,
  • Mohammed El Mzibri2,
  • Rachid Razine3, 4,
  • Zineb Qmichou2,
  • Mohammed Attaleb2 and
  • Mariam Amrani1Email author
Infectious Agents and Cancer20149:37

https://doi.org/10.1186/1750-9378-9-37

Received: 2 July 2014

Accepted: 10 October 2014

Published: 10 November 2014

Abstract

Introduction

The mouse mammary tumor virus (MMTV) like sequences have been reported to be present in some human breast cancers, but their association with breast cancer development is still controversial.

Methods

In this retrospective study, we investigated the status of MMTV-like in 42 tumor biopsies and 18 paired normal tissues from Moroccan patients with breast cancer. MMTV-like env sequences were identified by PCR and confirmed by direct DNA sequencing.

Results

Specific MMTV-like env sequences were found in 24 (57.14%) cases of breast carcinomas, and 6 (33.3%) cases of matched normal breast tissues. Comparison to sociologic and clinicopathological parameters showed no significant association between the presence of MMTV-like sequences and age, menopausal status, histological subtype, histological grade, tumor size and the expression of hormone receptors (estrogen ER and/or progesterone PgR) and Her 2. However, a significant correlation was found between MMTV-like presence and parity (p = 0.024).

Conclusions

This present study confirms the presence of MMTV-like env sequences in breast cancer in Moroccan women, prompting further evaluation, on large sampling, to elucidate the probable causal roles of MMTV-like in breast cancer development.

Keywords

Breast cancer MMTV-like Morocco

Background

Worldwide, breast cancer is the leading cancer in women with approximately1.38 million new cases per year and 458.000 deaths annually [1]. In Morocco, breast cancer is the most predominant cancer and represents a great public health problem, with an age-standardized incidence rate (ASR) of 49.2 per 100 000 women [2].

Nowadays, multiple factors are associated with an increased risk of breast cancer, including age, gender, ethnicity, past history of breast cancer, reproductive and hormonal factors, family history and genetic factors, exposure to ionizing radiation, and environmental and lifestyle factors [3]. A high estrogen level is suspected to increase breast cancer risk, and other hormones such as progesterone, androgen derived from the ovaries and adrenal, thyroid hormones and insulin may play important roles in breast cancer development [3]. However, it’s widely accepted that hereditary transmission of some predisposition genes, especially BRCA1 and BRCA2, are the most known factors to be directly involved in the pathogenesis of breast cancer and is associated with 5–10% of breast cancer cases [4].

Since the discovery of the role of mouse mammary tumor virus (MMTV) as the causal agent of mammary tumor in mice [5], the viral etiology of human breast cancer has gained a growing interest. DNA sequences showing homology to those of MMTV virus have been detected in human breast cancer, suggesting that this virus called MMTV-like, also called Human Mammary Tumor Virus (HMTV), could be the human form of the MMTV and may be involved in the development of human breast cancer [69].

More recently, several studies have demonstrated the presence of MMTV-like env sequences in 30 – 40% of breast cancer cases in several Western countries including the United States, Italy, Brazil and Argentina [10]. Overall, the prevalence of MMTV-like ranges between 78% in Australia to 0% in Iran, Mexico, Germany and Japan [1115].

Thus, the present study is the first one to be undertaken to determine the presence of MMTV-like in a set of Moroccan breast cancer samples and to evaluate the association between MMTV-like infection and some clinicopathological parameters. The aim of this study is to evaluate the involvement of MMTV-like in the development of breast cancer.

Methods

Samples

In this retrospective study, 42 formalin fixed paraffin embedded samples were collected at the pathology department of the National Institute of Oncology in Rabat from patients with breast cancer. To evaluate the presence of MMTV-like in non cancerous tissues, paired normal tissues from 18 patients were also analyzed. For these cases, sampling was done at least 2 cm away from the tumor. No consent was needed for this retrospective study. The study protocol was approved by the Ethical Committees of the Faculty of Medicine and Pharmacy of Rabat.

Clinicopathological parameters

All the data were retrieved from patients’ medical files, including age, parity, menopausal status, histological type and grade, tumor size, hormonal status and Her2 assessment.

Hormonal receptors (ER, PgR) were considered positive when ER and /or PgR were positive. The positive cut off is nuclear staining in at least 10% of tumor cells with any intensity.

DNA extraction

Sections of paraffin blocks were treated first with xylene to dissolve the paraffin and with ethanol to remove the remaining xylene. Cells were then lysed in the digestion buffer (Tris–HCl pH 8.0 10 mM, EDTA 10 mM, NaCl150 mM and SDS 2%) containing proteinase K (0.1 mg/ml). DNA isolation was performed with phenol-chloroforme extraction and ethanol precipitation. DNA was then resuspended in sterile distilled water [16]. The tissue DNA was precipitated with 2/5 volumes of 7.4 M ammonium acetate and 2 volumes of 100% ethanol, followed by incubation at -20°C and centrifugation at top speed (13000 relative centrifugal force). DNA was then resuspended in 25–30 μL of sterile distilled water and stored at -20°C until use. In order to evaluate the efficiency of DNA extraction, all samples were amplified by Polymerase Chain Reaction (PCR) using PC04 and GH20 primers specific for human β-globin gene (Table 1).
Table 1

List of primers used for PCR amplification and DNA sequencing

 

Primer

Fragment generated size

Sequence

Tm (°C)

β-globin

PC04

268 bp

5′-CAACTTCATCCACGTTCACC-3′

54.5

GH20

5′-GAAGAGCCAAGGACAGGTAC-3′

MMTV-like detection

489 F*

171 bp

5′-ACCAGGGGGTGAGTTTTTCT-3′

57

659R*

5′-CCCATCCTGCYTCATACCAT-3′

*F: Forward primer; *R: Reverse primer.

Detection of MMTV-like sequences by PCR

MMTV-like detection was performed by PCR using MMTV659R/MMTV489F primers (Table 1). These primers amplify a fragment of 171 bp of MMTV-like highly conserved in the env gene encoding the viral coat protein.

Amplification reaction was performed in a total volume of 25 μl. The amplification mixture contained 0.4 μM of each primer, 200 μM of each dNTP (dATP, dCTP, dGTP and dUTP), 0.5 units Taq DNA polymerase (Promega, France) and 3 μl of DNA sample in 1× Taq polymerase buffer. For every reaction, a negative control in which DNA template was omitted from the amplification mixture, and a positive control (MMTV DNA) were included. The thermal cycler (Gene Amp, PCR system 9700, Applied Biosystem, Foster city, CA) was programmed for 40 cycles with an initial denaturation at 94°C for 4 min. Each cycle was performed with a denaturation at 94°C for 30 sec, annealing at 57°C for 1 min and extension at 72°C for 1 min 30 sec. At the end of the last cycle, the mixtures were incubated at 72°C for 10 min.

The amplified products were submitted to electrophoresis on a 2% agarose gel in 1× Tris-borate-EDTA buffer at pH of 8.6. The gel was stained with ethidium bromide of 10 mg/ml 2 μL in 100 mL of 1× Tris-borate-EDTA, and the 171-bp amplified bands were visualized on an ultraviolet transilluminator to check for DNA amplification.

DNA sequencing

For each PCR product, both strands were sequenced, in independent reactions, using MMTV659R/MMTV489F primers. Firstly, the PCR products were purified by the ExoSaP-IT clean up system (USB, USA).Direct sequencing was performed on an ABI 3130XL DNA analyzer (Applied Biosystems, Foster city, CA, USA), using the sequencing primer and BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster city, CA, USA), according to manufacturer’s protocol. Nucleotides sequences were aligned and compared to the reference sequence of MMTV-like (Accession number: AF243039) and MMTV (Accession number: AY152721).

Statistical analysis

Categorical variables were expressed as numbers and percentages, and continuous variables were expressed as means ± SD or median (interquartile range). Data were analyzed using the statistical soft-ware SPSS version 13.0.

The results were compared using the Chi2 test to identify associations between the different collected parameters and MMTV-like status. The statistical relationship was considered as significant if the derived p value was < 0.05.

Results and discussion

Results

The mean age of patients was 41.6 [36.00 – 49.25] years, with extreme ages at 27 and 73. Among the 42 recruited patients, 29 were diagnosed having Inflammatory Breast Cancer (IBC) (69%) while the remaining 13 cases were Non Inflammatory Breast Cancer (NIBC) (31%). Interestingly, more than 78% of the patients were premenopausal and 31.71% were nulliparous.

The pathological results of the 42 breast cancer cases are reported in Table 2. Except for one patient who had Invasive Lobular Carcinoma (ILC), all the patients (97.62%) were diagnosed with Invasive Ductal Carcinoma (IDC).
Table 2

Pathological Characteristics of the 42 breast cancer cases

Characteristics

Number of cases (%)

Menopausal status

Pre-menopausal

33 (78.57)

Post-menopausal

9 (21.43)

Histological type

Invasive ductal carcinoma

41 (97.62)

Invasive lobular carcinoma

1 ( 2.38)

Histological grade

I

3 ( 7.14)

II

18 (42.86)

III

21 (51.22)

Tumor size

≤20 mm

3 ( 7.14)

20-50 mm

18 (41.86)

>50 mm

21 (51.22)

Histopathologicalgrade II and III were the most frequent with a large tumor size in half of the cases (Table 2).

Immunohistochemistry analysis showed that hormone receptors were positive in 78.57%. The human epidermal growth factor receptor 2 (Her2) status was positive in 28.57% of the cases (Table 3).
Table 3

Hormone receptors and Her2 results of the 42 breast cancer cases

Marker

Number of cases (Percentage)

ER

Positive

19 (45.24)

Negative

23 (54.76)

PgR

Positive

32 (76.19)

Negative

10 (23.81)

Her2

Positive

12 (28.57)

Negative

30 (71.43)

The presence of amplifiable DNA was confirmed for all 42 cases by PCR based-technique using primers for a fragment of β-globin gene and therefore all DNA samples were adequate for further analysis. Molecular detection of MMTV-like DNA, using PCR amplification of a conserved region of the viral env gene DNA, revealed the presence of viral DNA in 57.14% of breast cancer cases (24 of 42).

MMTV-like detection was also performed on 18 normal tissues anatomically related to tumor tissues, from patients with breast cancer. Results showed that 33.3% of cases are MMTV-like positive (6/18). Among them, 3 cases have MMTV-like env sequences in both normal and tumoral tissues whereas 3 cases have shown the absence of viral sequences in tumoral tissues.

The comparison of the clinicopathological and immunohistochemical data between the MMTV-like positive and MMTV-like negative breast cancer cases is summarized in Table 4. Overall, no association was found between the presence of MMTV-like sequences and age, menopausal status, the histological type, the SBR grade and the tumor size. Moreover, immunohistochemical expression of hormone receptors and Her2 did not vary significantly between MMTV-like positive and MMTV-like negative samples. However, our results clearly showed asignificant correlation between the presence of MMTV-like sequences and parity (P = 0,024).
Table 4

Correlation of MMTV-like status according to the clinicopathological parameters of breast cancer cases

Variables

N

Positive MMTV-like samples (%)

Negative MMTV-like samples (%)

P-value

Age

    

  <35 years

8

2 (25)

6 (75)

0,093

  35-50 years

26

16 (61.5)

10(38.5)

 

  >50 years

8

6 (75)

2 (25)

 

Nulliparity

    

  Yes

13

4 (30.8)

9 (69.2)

0,024

  No

29

20 (69)

9 (31)

 

Menopausal status

    

  Pre-menopausal

35

19 (54.3)

16 (45.7)

0,344

  Post-menopausal

7

5 (71.4)

2 (28.6)

 

Inflammatory breast cancer

    

  Yes

29

19 (65.5)

10 (34.5)

0,097

  No

13

5 (38.5)

8 (61.5)

 

SBR grade

    

  I

2

1 (50.0)

1 (50)

0,762

  II

23

12 (52.2)

11 (47.8)

 

  III

17

11 (64.7)

6 (35.3)

 

Tumor size

    

  ≤20 mm

3

3 (100)

0 (0)

0,348

  20-50 mm

18

9 (50)

9 (50)

 

  >50 mm

21

12 (57)

9 (43)

 

ER

    

  +

19

9 (47.4)

10 (52.6)

0,349

  -

23

15 (65.2)

8 (34.8)

 

PgR

    

  +

32

20 (62.5)

12 (37.5)

0,281

  -

10

4 (40)

6 (60)

 

Her2

    

  +

12

7 (58.3)

5(41.7)

0,600

  -

30

17 (56.7)

13(43.3)

 
All samples identified as positive for MMTV-like env sequence were sequenced in order to confirm the presence of MMTV-like in breast cancer samples. The complete PCR products’ sequences, aligned to MMTV and MMTV-like sequences are reported in Figure 1. Multiple nucleotide alignment showed 95-99% homology to MMTV and MMTV-like env sequences.
Figure 1

Multiple nucleotide alignment of the MMTV-like env sequences of 24 human breast carcinomas with the MMTV C3H (GenBank: AF228552.1) and MMTV-like SAG pseudogene (GenBank AF243039.1) reference sequences.

Overall, 8 point mutations and 1 deletion were found when comparing obtained sequences to the MMTV-like reference sequence. Interestingly, the point mutation G6241A is present in all analysed samples. Moreover, 10 of 24 cases have a nucleotide A at position 623, as the MMTV-like sequence, whereas the remaining 14 cases had a G, as the MMTV sequence.

Discussion

Worldwide, the viral etiology of breast cancer is largely discussed and remains controversial. During lasts decades, there is a resurgence of interest in a potential role of MMTV-like, a retrovirus homologue of MMTV involved in breast cancer in mice [17].

Many studies have reported that sequences highly homologous to MMTV were found in up of 40% of human breast cancers [18]. To our knowledge, this study is the first one conducted in Morocco to assess the involvement of MMTV-like in the development of breast cancer.

In our current study, the viral sequences were detected in 57.14% of cases. Additionally, the MMTV-like env sequences detected in our cases were highly homologous to the MMTV and the MMTV-like sequences reported previously [19, 20]. MMTV-like detection in African countries is limited to the Tunisian population as reported by Levine et al. [21] and Hachana et al. [22]. The breast cancer samples analysed by Levine et al. [21] were characterized by the predominance of the inflammatory form and showed a high frequency of MMTV-like (74%). However, in the study of Hachana et al. [22], inflammatory breast carcinoma was found only in 1.6% of cases (2/122), and only 14% of cases were MMTV-like positives. This difference suggested a correlation between MMTV-like and inflammatory breast cancer. In our study, MMTV-like was found in both inflammatory and non inflammatory breast cancer cases.

The association of MMTV-like and the inflammatory form of breast cancer was developed in a study of inflammatory breast cancer in the United States evaluating biospecimens obtained from patients enrolled in the North American inflammatory breast cancer registry. Reported data clearly showed that 71% of inflammatory breast cases were MMTV-like positives, as compared with 40% of non-inflammatory breast cancer cases (P < .0001) [23].

In addition, there were major geographic differences. In low incidence countries of breast cancer, MMTV-like env sequences were detected in less than 17% of cases. Indeed, studies of breast cancer cases from Japan and China have detected MMTV-like env sequences respectively in 12% [24] and 16.8% of tumors [25].In contrast, our result concords with the other studies performed in high-incidence countries of breast cancer, such as the United States where MMTV-like sequences were identified in 40–70% of breast cancer cases [23]. Similarly, studies of breast cancer cases from Argentina have detected MMTV-like sequences in 31.7% of the tumors [26, 27]. Interestingly, Mazzanti et al. have reported the presence of MMTV-like env sequence in 82% of ductal carcinoma in situ, but only in 35% of infiltrating ductal carcinoma [28]. In Australia, many studies have been conducted and showed a large discrepancy. Ford et al. [9] have reported MMTV-like sequences in 40% of breast cancer cases, but more recently a study conducted by Glenn et al. [29] revealed the presence of MMTV-like in 78% of the cases which is the highest frequency published up to now.

On the other hand, other studies conducted in England, Iran, Germany and Mexico, have never found the MMTV-like sequences in their breast cancer samples [30, 1214].

The observed differences could be explained by the technique used in the detection of the MMTV-like sequences; the quality of DNA obtained from breast cancer biopsies and could also be related to the prevalence of Musdomesticus in these regions. In fact, it’s widely accepted that mice might act as a reservoir and transmit the virus to humans [17]. Moreover, human breast cancer is higher in geographic areas (e.g., Western Europe, USA) where Mus domesticus is the most prevalent mouse species than other regions (e.g., Asia) and that M. domesticus mice produce more MMTV as they carry more exogenous virus and have more endogenous proviral loci than M. musculus[17].

In this study, MMTV-like sequences were found in 33.3% of normal tissues sampled at least 2 cm away from the tumor. Many studies have investigated the presence of MMTV DNA in normal tissues and showed the presence of MMTV-like env sequences in 0-19% [9, 22, 28]. The presence of viral DNA in normal tissues was largely discussed and all converge to the exogenous origin of the virus infection [17].Moreover, the high frequency of MMTV-like env sequences in our cases could be due to the sensitivity of the technique of detection. Indeed, the nested PCR used in our study, which is more sensitive than PCR, is often needed to detect the presence of virus DNA, because of low-level infections in humans, in contrast to mice [17].

Interestingly, MMTV-like env sequences were detected in normal tissues from 3 patients with breast cancer and not in the paired tumoral tissues. For these cases, breast cancer could have another origin and patients were on-infected by the virus. Therefore, it will be interesting to follow-up closely these patients to evaluate the outcome of the disease in the presence of the virus.

In the present study, the analysis of clinicopathological parameters showed no significant correlation between the presence of MMTV-like sequences and histological subtype, histological grade, tumor size, hormone receptors and Her 2 expression, suggesting that the infection by the MMTV-like is not associated with the tumor subgroups examined and the evolution of the disease. According to age, and even if it’s not statistically significant, the viral DNA is more frequent in elderly women leading to a trend association between viral infection and patients age, suggesting that MMTV-like may be a contributing factor in human breast carcinogenesis and breast cancer related MMTV-like requires more time for cancer development.

However, a significant association was found between MMTV-like positive samples and parity. This could be explained by the modification of breast tissues during pregnancy and breastfeeding. Indeed, the breast tissues are subject to continuous transformation. Thus, after pregnancy the breast tissue could be more susceptible to viral infection [31].

Conclusion

In conclusion, our study clearly shows the presence of MMTV-like env sequence in breast cancer cases in Morocco. This study prompts to conduct further evaluations, on large sampling, to elucidate the probable causal roles of MMTV-like in breast cancer development.

Abbreviations

BC: 

Breast cancer

MMTV: 

Mouse mammary tumor virus

ASR: 

Age-standardized incidence rate

HMTV: 

Human mammary tumor virus

PCR: 

Polymerase chain reaction

IBC: 

Inflammatory breast cancer

NIBC: 

Non inflammatory breast cancer

ILC: 

Invasive LobularCarcinoma

IDC: 

Invasive DuctalCarcinoma

PgR: 

Progesterone receptor

ER: 

Estrogen receptor

Her2: 

Human epidermal growth factor receptor 2.

Declarations

Acknowledgements

The authors would like to thank Dr. Hugo Arias-Pulido from The University of New Mexico for his contribution in the development of the experimental protocol and the donation of positive control of MMTV.

Authors’ Affiliations

(1)
Equipe de recherche ONCOGYMA, University of Mohamed V-Souissi, Faculty of Medicine and Pharmacy of Rabat
(2)
Unité de Biologie et Recherche Médicale, Centre National de l’Energie, des Sciences et des Techniques Nucléaires
(3)
Laboratory of Biostatistics, Epidemiology and Clinical Research, Université Mohamed V-Souissi Faculty of Medicine and Pharmacy of Rabat
(4)
Department of Public Health, Université Mohamed V-Souissi Faculty of Medicine and Pharmacy of Rabat

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127: 2893-2917. 10.1002/ijc.25516.PubMedView ArticleGoogle Scholar
  2. Registre des Cancers de la Région du grand Casablanca. 2005, Edition 2012: Ministry of health of Morocco, -2006-2007Google Scholar
  3. Jung SJ, Song M, Choi JY, Song N, Park SK, Yoo KY, Kang D: Association of selected medical conditions with breast cancer risk in Korea. J Prev Med Public Health. 2013, 46 (6): 346-352. 10.3961/jpmph.2013.46.6.346.PubMedPubMed CentralView ArticleGoogle Scholar
  4. Yoshida K, Miki Y: Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004, 95: 866-871. 10.1111/j.1349-7006.2004.tb02195.x.PubMedView ArticleGoogle Scholar
  5. Bittner JJ: The milk influence of breast tumor in mice. Science. 1942, 95: 462-463. 10.1126/science.95.2470.462.PubMedView ArticleGoogle Scholar
  6. Black MM, Zachrau RE, Shore B, Moore DH, Leis HP: Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus. Cancer. 1975, 35 (1): 121-128. 10.1002/1097-0142(197501)35:1<121::AID-CNCR2820350117>3.0.CO;2-W.PubMedView ArticleGoogle Scholar
  7. Etkind P, Du J, Khan A, Pillitteri J, Wiernik PH: Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res. 2000, 6: 1273-1278.PubMedGoogle Scholar
  8. Melana SM, Holland JF, Pogo BG: Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res. 2001, 7: 283-284.PubMedGoogle Scholar
  9. Ford CE, Tran D, Deng Y, Ta VT, Rawlinson WD, Lawson JS: Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin Cancer Res. 2003, 9: 1118-1120.PubMedGoogle Scholar
  10. Wang Y, Jiang JD, Xu D, Li Y, Holland JF, Qu C, Pogo BGT: A MMTV-like LTR superantigen in human breast cancer. Cancer Res. 2004, 64: 4105-4111. 10.1158/0008-5472.CAN-03-3880.PubMedView ArticleGoogle Scholar
  11. Ford CE, Faedo M, Rawlinson WD: Mouse mammary tumor virus-like RNA transcripts and DNA are found in affected cells of human breast cancer. Clin Cancer Res. 2004, 10: 7284-7289. 10.1158/1078-0432.CCR-04-0767.PubMedView ArticleGoogle Scholar
  12. Tabriz HM, Zendehdel K, Shahsiah R, Fereidooni F, Mehdipour B, Hosseini ZM: Lack of detection of the mouse mammary tumor-like virus (MMTV) Env gene in Iranian women breast cancer using real time PCR. Asian Pac J Cancer Prev. 2013, 14 (5): 2945-2948. 10.7314/APJCP.2013.14.5.2945.PubMedView ArticleGoogle Scholar
  13. Morales-Sánchez A, Molina-Muñoz T, Martínez-López JLE, Hernández-Sancén P, Mantilla A, Leal YA, Torres J, Fuentes-Pananá EM: No association between Epstein-Barr virus and mouse mammary tumor virus with breast cancer in Mexican women. Sci Rep. 2013, 3: 2970-2977.PubMedPubMed CentralView ArticleGoogle Scholar
  14. Frank O, Verbeke C, Schwarz N, Mayer J, Fabarius A, Hehlmann R, Leib-Mösch C, Seifarth W: Variable transcriptional activity of endogenous retroviruses in human breast cancer. J Virol. 2008, 82: 1808-1818. 10.1128/JVI.02115-07.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Fukuoka H, Moriuchi M, Yano H, Nagayasu T, Moriuchi H: No association of mouse mammary tumor virus-related retrovirus with Japanese cases of breast cancer. J Med Virol. 2008, 80: 1447-1451. 10.1002/jmv.21247.PubMedView ArticleGoogle Scholar
  16. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor, New York: Cold Spring Harbor LaboratoryGoogle Scholar
  17. Salmons B, Gunzburg WH: Revisiting a role for a mammary tumor retrovirus in human breast cancer. Int J Cancer. 2013, 133: 1530-1536. 10.1002/ijc.28210.PubMedView ArticleGoogle Scholar
  18. Joshi D, Buehring GC: Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat. 2012, 135: 1-15. 10.1007/s10549-011-1921-4.PubMedView ArticleGoogle Scholar
  19. Ono M, Yasunaga T, Miyata T, Ushikubo H: Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol. 1989, 60: 589-598.Google Scholar
  20. Wang Y, Holland JF, IBleiweiss IJ, Melana S, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S, Pogo BGT: Detection of mammary tumor virus ENV gene-like sequences in human breast cancer. Cancer Res. 1995, 55: 5173-5179.PubMedGoogle Scholar
  21. Levine PH, Pogo BG, Klouj A, Coronel S, Woodson K, Melana SM, Mourali N, Holland JF: Increasing evidence for a human breast carcinoma virus with geographic patterns. Cancer. 2004, 101: 721-726. 10.1002/cncr.20436.PubMedView ArticleGoogle Scholar
  22. Hachana M, Trimeche M, Ziadi S, Amara K, Gaddas N, Mokni M, Korbi S: Prevalence and characteristics of the MMTV-like associated breast carcinomas in Tunisia. Cancer Lett. 2008, 271: 222-230. 10.1016/j.canlet.2008.06.001.PubMedView ArticleGoogle Scholar
  23. Pogo BGT, Holland JF, Levine PH: Human mammary tumor virus in inflammatory breast cancer. Cancer. 2010, 116: 2741-2744. 10.1002/cncr.25179.PubMedView ArticleGoogle Scholar
  24. Holland JF, Melana S, Wang Y, Fernandez-Cobo M, Jiang JD, Pogo BG: Human mammary tumor virus (HMTV) is horizontally, not vertically transmitted. Proc Am Soc Clin Oncol. 2003, 22: 873-Google Scholar
  25. Luo T, Wu XT, Zhang MM, Qian K: Study of mouse mammary tumor virus-like gene sequences expressing in breast tumors of Chinese women. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006, 37: 844-846.PubMedGoogle Scholar
  26. Melana SM, Picconi MA, Rossi C, Mural J, Alonio LV, Teyssie A, Holland JF, Pogo BG: Detection of murine mammary tumor virus (MMTV) env gene-like sequences in breast cancer from Argentine patients. Medicina. 2002, 62: 323-327.PubMedGoogle Scholar
  27. Lawson JS, Glenn WK, Salmons B, Ye Y, Heng B, Moody P, Johal H, Rawlinson WD, Delprado W, Lutze-Mann L, Whitaker NJ: Mouse mammary tumor virus-like sequences in human breast cancer. Cancer Res. 2010, 70 (9): 3576-3585. 10.1158/0008-5472.CAN-09-4160.PubMedView ArticleGoogle Scholar
  28. Mazzanti CM, Al Hamad M, Fanelli G, Scatena C, Zammarchi F, Zavaglia K, Lessi F, Pistello M, Naccarato AG, Bevilacqua G: A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma. Am J Pathol. 2011, 179 (4): 2083-2090. 10.1016/j.ajpath.2011.06.046.PubMedPubMed CentralView ArticleGoogle Scholar
  29. Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS: Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One. 2012, 7 (11): e48788-10.1371/journal.pone.0048788.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Mant C, Gillett CD, Arrigo C, Cason J: Human murinemammary tumor virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cell lines or biopsies. Virology. 2004, 318: 393-403. 10.1016/j.virol.2003.09.027.PubMedView ArticleGoogle Scholar
  31. Moore KL: Anatomie médicale: aspects fondamentaux et applications cliniques. De Boeck Supérieur. 2001, USA: Lippincott Williams & WilikinsGoogle Scholar

Copyright

© Slaoui et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.